PDF (1878K)
摘要
目的 回顾性分析异基因造血干细胞移植(allo-HSCT)患者治疗期间血液成分输注特征和造血重建时间差异,识别影响血液输注和造血重建的因素,为优化干细胞采集策略及制定个性化输血治疗方案提供依据。方法 选择 2023 年 1 月-2025 年 12 月于本院接受 allo-HSCT 治疗的 95 例患者,分析不同疾病分类、HLA 配型状态、ABO 血型相合情况以及移植物中细胞成分数量等资料,比较不同组间红细胞和血小板输注量及造血重建时间的差异,评价影响血液输注和造血重建时间的影响因素。结果 不同疾病分类对红细胞和血小板的输注量无影响;HLA 半相合与全相合状态、ABO 血型相合性和移植物中血小板数量对血液成分输注量及造血重建时间的差异不具有统计学意义;移植物中 MNC 数量(6~10)×106/kg 组仅粒系重建时间(d)与(2~ 4) ×106/kg 组差异具有统计学意义[12. 00 (11. 00,13. 00)vs. 18. 00(17. 00,30. 00),P<0. 05];移植物中 CD34+细胞数量(6 ~ 10) ×106/kg 组血小板输注量、粒系重建时间和血小板重建时间分别为 3. 00(3. 00,4. 00) 治疗量、11. 00(10. 25,13. 75) d、12. 00(11. 00,14. 00) d,(>10)×106/kg 组血小板输注量、粒系重建时间和血小板重建中位时间分别为 3. 00(2. 00,3. 25) 治疗量、11. 50 (10. 00,12. 00)d、12. 00(11. 00,13. 00)d,分别与(2~ 4) ×106/kg 组血小板输注量[6. 00(3. 00,8. 00)治疗量]、粒系重建时间[13. 00(12. 00,15. 00)d]、血小板重建时间[15. 00(15. 50,22. 50) d] 差异均具有统计学意义(P<0. 05),CD34+<4×106/kg 组粒系和血小板重建延迟且输注血小板需求显著增加。结论 移植物中 CD34+细胞数量是 allo-HSCT 后造血重建延迟的显著相关因素,且对血小板输注量有显著影响。 血液输注是接受 allo-HSCT 的患者支持治疗的必要措施,优化干细胞采集程序以确保移植物中 CD34+细胞目标数量,并依据移植物 CD34 +计数预先制定个性化输血策略,将有助于促进造血重建、降低输血负担,改善患者移植预后。
Abstract
Objective To show the characteristics of blood component transfusion and differences in hematopoietic reconstitution time among patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) retrospectively, with the aim of identifying factors affecting blood transfusion and hematopoietic reconstitution, and providing evidence for optimizing stem cell collection strategies and developing individualized transfusion regimens. Methods A total of 95 patients who received allo-HSCT treatment in our hospital from January 2023 to December 2025 were enrolled. Data including disease classification, HLA matching status, ABO blood group compatibility, and cellular composition of grafts were analyzed, and differences in red blood cell and platelet transfusion requirements, as well as the hematopoietic reconstitution time, were compared among groups. Factors affecting transfusion requirements and hematopoietic reconstitution time were evaluated. Results Different disease classifications showed no significant effect on red blood cell or platelet transfusion requirements. No statistically significant differences were observed in blood component transfusion volumes or hematopoietic reconstitution time between HLA semi-matched and fully matched status, ABO blood group compatibility, and graft platelet count. A statistically significant difference was observed only in granulocyte engraftment time between the graft MNC count group of (6-10)×106/kg and the (2-4) ×106/kg group[12. 00 (11. 00, 13. 00) vs 18. 00 (17. 00, 30. 00) days, P<0. 05]. Regarding graft CD34+cell count, the (6-10) ×106/kg group had a platelet transfusion volume of 3. 00 (3. 00, 4. 00) therapeutic units, with granulocyte and platelet engraftment time of 11. 00 (10. 25, 13. 75) days and 12. 00 (11. 00, 14. 00) days, respectively; the (>10)×106/kg group had corresponding values of 3. 00 (2. 00, 3. 25) therapeutic units, 11. 50 (10. 00, 12. 00) days, and 12. 00 (11. 00, 13. 00) days.compared with the (2-4) × 106/kg group [6. 00 (3. 00, 8. 00) therapeutic units, 13. 00 (12. 00, 15. 00) days, 15. 00 (15. 50, 22. 50) days], all these differences were statistically significant (P<0. 05). Patients in the CD34+< 4×106/kg group demonstrated delayed granulocyte and platelet engraftment and significantly increased platelet transfusion requirements. Conclusion The CD34+cell dose in the graft is a significant correlate of hematopoietic reconstitution time after allo-HSCT and is significantly associated with platelet transfusion requirements. Blood transfusion is a necessary measure for supportive treatment of allo-HSCT patients. Optimizing stem cell harvesting protocols to achieve the target CD34+cell dose, along with developing individualized transfusion strategies based on graft CD34+counts, may facilitate hematopoietic recovery, reduce transfusion burden, and ultimately improve patient outcomes after transplantation.
关键词
Key words
[Author(id=1329502486856348618, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wangrong@qdu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502486961206223, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, authorId=1329502486856348618, language=EN, stringName=Rong WANG, firstName=Rong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 Department of Blood Transfusion, The Affiliated Hospital of Qingdao University , Qingdao 206000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502487011537873, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, authorId=1329502486856348618, language=CN, stringName=王蓉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 青岛大学附属医院 输血科 山东 青岛 206000, bio={"content":"王蓉(1989-),女,副主任技师,Email:wangrong@qdu.edu.cn
"}, bioImg=null, bioContent=王蓉(1989-),女,副主任技师,Email:wangrong@qdu.edu.cn
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502486688576446, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, xref=1, ext=[AuthorCompanyExt(id=1329502486701159359, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, companyId=1329502486688576446, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Department of Blood Transfusion, The Affiliated Hospital of Qingdao University , Qingdao 206000, China), AuthorCompanyExt(id=1329502486717936576, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, companyId=1329502486688576446, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 青岛大学附属医院 输血科 山东 青岛 206000)])]), Author(id=1329502487057675218, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502487116395479, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, authorId=1329502487057675218, language=EN, stringName=Qing LIU, firstName=Qing, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2 Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University , Qingdao 206000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502487162532825, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, authorId=1329502487057675218, language=CN, stringName=刘青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2 青岛大学附属医院 检验科 山东 青岛 206000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502486764073922, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, xref=2, ext=[AuthorCompanyExt(id=1329502486776656836, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, companyId=1329502486764073922, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2 Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University , Qingdao 206000, China), AuthorCompanyExt(id=1329502486793434054, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, companyId=1329502486764073922, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2 青岛大学附属医院 检验科 山东 青岛 206000)])]), Author(id=1329502487208670172, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502487267390431, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, authorId=1329502487208670172, language=EN, stringName=Zifan MENG, firstName=Zifan, middleName=null, lastName=MENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 Department of Blood Transfusion, The Affiliated Hospital of Qingdao University , Qingdao 206000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502487313527779, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, authorId=1329502487208670172, language=CN, stringName=孟子凡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 青岛大学附属医院 输血科 山东 青岛 206000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502486688576446, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, xref=1, ext=[AuthorCompanyExt(id=1329502486701159359, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, companyId=1329502486688576446, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Department of Blood Transfusion, The Affiliated Hospital of Qingdao University , Qingdao 206000, China), AuthorCompanyExt(id=1329502486717936576, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, companyId=1329502486688576446, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 青岛大学附属医院 输血科 山东 青岛 206000)])]), Author(id=1329502487355470821, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=sxkzsq@126.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329502487409996777, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, authorId=1329502487355470821, language=EN, stringName=Shaoqiang ZHANG, firstName=Shaoqiang, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 Department of Blood Transfusion, The Affiliated Hospital of Qingdao University , Qingdao 206000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502487456134123, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, authorId=1329502487355470821, language=CN, stringName=张少强, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 青岛大学附属医院 输血科 山东 青岛 206000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502486688576446, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, xref=1, ext=[AuthorCompanyExt(id=1329502486701159359, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, companyId=1329502486688576446, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Department of Blood Transfusion, The Affiliated Hospital of Qingdao University , Qingdao 206000, China), AuthorCompanyExt(id=1329502486717936576, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329456925058252872, companyId=1329502486688576446, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 青岛大学附属医院 输血科 山东 青岛 206000)])])]
王蓉,刘青,孟子凡,张少强.
异基因造血干细胞移植患者输血及造血重建影响因素分析[J].
中国输血杂志, 2026, 39(9): 1246-1253 DOI:10.13303/j.cjbt.issn.1004-549x.2026.09.012
| [1] |
朱晓璐,黄晓军,王昱. 造血干细胞移植在急性髓系白血病中的应用进展[J].中华血液学杂志,2025,46(2):179-185.
|
| [2] |
ZHU X L, HUANG X J, WANG Y. Progress in hematopoietic stem cell transplantation for acute myeloid leukemia[J].Chin J Hematol,2025,46(2):179-185.
|
| [3] |
ROMMELEY M, SPIES-WEISSHART B, SCHILLING K, et al. Reconstitution and functional analyses of neutrophils and distinct subsets of monocytes after allogeneic stem cell transplantation[J].J Cancer Res Clin Oncol, 2011, 137(9):1293-1300.
|
| [4] |
SCOTT B L, PASQUINI M C, FEI M, et al. Myeloablative versus reduced-intensity conditioning for hematopoietic cell transplantation in acute myelogenous leukemia and myelodysplastic syndromes-long-term follow-up of the BMT CTN 0901 clinical trial[J].Transplant Cell Ther, 2021, 27(6):483. e1-483. e6.
|
| [5] |
潘波,官笑羽,王珏,等. 我国 2018-2023 年红细胞输血反应分析[J].中国输血杂志,2025,38(5):704-710.
|
| [6] |
PAN B, GUAN X Y, WANG J, et al. Analysis of red blood cell transfusion reactions in China from 2018 to 2023[J].Chin J Blood Transfusion,2025,38(5):704-710.
|
| [7] |
俞霞,马淑群,施明秀,等. 输血不良反应相关影响因素分析[J].检验医学与临床,2024,21(15):2254-2259.
|
| [8] |
YU X, MA S Q, SHI M X, et al. Analysis of related influencing factors of adverse reactions of blood transfusion[J].Lab Med Clin,2024,21(15):2254-2259.
|
| [9] |
MALARD F, JENQ R R. The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation[J].Cancer J, 2023, 29(2):75-83.
|
| [10] |
周雪莹,张美玉,魏海潮,等. 造血干细胞移植患者围术期用血情况分析[J].临床血液学杂志,2025,38(8):598-602.
|
| [11] |
ZHOU X Y, ZHANG M Y, WEI H C, et al. Analysis of perioperative blood use in patients with hematopoietic stem cell transplantation[J].J Clin Hematol,2025,38(8):598-602.
|
| [12] |
WANG C, ZHAO M, NIE Y, et al. Impact of iron overload on poor graft function after allo-HSCT in a patient with transfusion-dependent low-risk MDS:A case report and literature review[J].Medicine (Baltimore), 2022, 101(51):e32012.
|
| [13] |
LAI D, CHEN D, CHEN X, et al. Effect of major ABO blood group mismatched HSCT on blood transfusion and clinical outcomes in AA patients[J].Ann Hematol, 2025, 104(3):1931-1947.
|
| [14] |
XUE R, DAI M, JIANG E, et al. Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT:a secondary analysis of an RCT[J].Blood Cancer J, 2025, 15(1):21.
|
| [15] |
罗小华,陈玉婷,王兰,等. 急性髓系白血病造血干细胞移植后间皮素特异性 T 细胞免疫重建初步研究[J].中国免疫学杂志,2025,41(9):2237-2242.
|
| [16] |
LUO X H, CHEN Y T, WANG L, et al. Mesothelin-specific T-cell immune reconstitution after hematopoietic stem cell transplantation in acute myeloid leukemia[J].Chin J Immunol,2025,41(9):2237-2242.
|
| [17] |
MCDONALD G B, SANDMAIER B M, MIELCAREK M, et al. Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation:comparing 2003-2007 versus 2013-2017 cohorts[J].Ann Intern Med, 2020, 172(4):229-239.
|
| [18] |
MCCURDY S R, KASAMON Y L, KANAKRY C G, et al. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide[J].Haematologica, 2017, 102(2):391-400.
|
| [19] |
KASAMON Y L, BOLAÑOS-MEADE J, PRINCE G T, et al. Outcomes of nonmyeloablative hla-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults[J].J Clin Oncol, 2015, 33(28):3152-3161.
|
| [20] |
KASAMON Y L, LUZNIK L, LEFFELL M S, et al. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide:effect of HLA disparity on outcome[J].Biol Blood Marrow Transplant, 2010, 16(4):482-489.
|
| [21] |
PENACK O, MARCHETTI M, ALJURF M, et al. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies:updated consensus recommendations of the European Society for Blood and Marrow Transplantation[J].Lancet Haematol, 2024, 11(2):e147-e159.
|
| [22] |
朱晓璐,黄晓军,王昱. 造血干细胞移植在急性髓系白血病中的应用进展[J].中华血液学杂志,2025,46(2):179-185.
|
| [23] |
ZHU X L, HUANG X J, WANG Y. Progress in hematopoietic stem cell transplantation for acute myeloid leukemia[J].Chin J Hematol,2025,46(2):179-185.
|
| [24] |
HIROKAWA M, FUKUDA T, OHASHI K, et al. Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors[J].Biol Blood Marrow Transplant, 2013, 19(7):1026-1032.
|
| [25] |
ROWLEY S D, DONATO M L, BHATTACHARYYA P. Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation[J].Bone Marrow Transplant, 2011, 46(9):1167-1185.
|
| [26] |
李小飞,马春娅,侯瑞琴. ABO 血型不合异基因造血干细胞移植受者血型检测与血液成分输注专家共识[J].中国输血杂志,2023,36(11):971-977.
|
| [27] |
LI X F, MA C Y, HOU R Q. Expert consensus on recipient blood type test and blood component transfusion after ABO-incompatibility hematopoietic stem cell transplantation[J].Chin J Blood Transfusion,2023,36(11):971-977.
|
| [28] |
WELLS J R, KANG G, SULIMAN A Y, et al. Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children[J].Bone Marrow Transplant, 2022, 57(8):1347-1349.
|
| [29] |
刘代红,黄晓军,陈欢,等. 异基因造血干细胞移植后供者外周血造血干细胞输注预防高危白血病复发[J].中华血液学杂志,2006,27(1):6-9.
|
| [30] |
LIU D H, HUANG X J, CHEN H, et al. Donor peripheral hematopoietic stem cells infusion for prophylaxis of relapse of high risk leukemia after allogeneic hematopoietic stem cell transplantation[J].Chin J Hematol,2006,27(1):6-9.
|
| [31] |
苗莹莹,张根玲,冉茜,等. 健康供者异基因外周血造血干细胞移植采集因素分析[J].中国输血杂志,2020,33(9):914-917.
|
| [32] |
MIAO Y Y, ZHANG G L, RAN Q, et al. Collection factors associated with allogeneic peripheral blood hematopoietic stem cell yield in healthy donors[J].Chin J Blood Transfusion,2020,33(9):914-917.
|
| [33] |
SHAHZAD M, SIDDIQUI R S, ANWAR I, et al. Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation:a systematic review and meta-analysis[J].Transplant Cell Ther, 2021, 27(10):877. e1-877. e8.
|